These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22269932)

  • 61. In a bundling era, finding a fair price for ESRD services.
    Sullivan JD
    Nephrol News Issues; 2007 Mar; 21(4):37, 39-40. PubMed ID: 17393926
    [No Abstract]   [Full Text] [Related]  

  • 62. New Medicare payment rules encourage home dialysis, but how to get patients started?
    Neumann ME
    Nephrol News Issues; 2011 Nov; 25(12):17. PubMed ID: 22204163
    [No Abstract]   [Full Text] [Related]  

  • 63. The prospective payment system: information for the medical librarian and a selected annotated bibliography.
    Grotzinger KM
    Med Ref Serv Q; 1985; 4(1):39-79. PubMed ID: 10311109
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterizing hospitalizations of end-stage renal disease patients on dialysis and inpatient utilization of erythropoiesis-stimulating agent therapy.
    Brophy DF; Daniel G; Gitlin M; Mayne TJ
    Ann Pharmacother; 2010 Jan; 44(1):43-9. PubMed ID: 20028955
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A quarter century of medicare expenditures for ESRD.
    Eggers PW
    Semin Nephrol; 2000 Nov; 20(6):516-22. PubMed ID: 11111852
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparing VA and private sector healthcare costs for end-stage renal disease.
    Hynes DM; Stroupe KT; Fischer MJ; Reda DJ; Manning W; Browning MM; Huo Z; Saban K; Kaufman JS;
    Med Care; 2012 Feb; 50(2):161-70. PubMed ID: 21945972
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The 2011 ESRD prospective payment system: perspectives of a home dialysis patient advocate.
    Peckham B
    Am J Kidney Dis; 2011 Apr; 57(4):559-61. PubMed ID: 21333429
    [No Abstract]   [Full Text] [Related]  

  • 68. [When to start dialysis. The predialysis patient].
    Triolo G; Savoldi S
    G Ital Nefrol; 2008; 25 Suppl 41():S9-12, discussion S13-20. PubMed ID: 18473314
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Implications of the End-Stage Renal Disease Treatment Choices Model among U.S. Dialysis Providers.
    Paulus AB; Howard AD; Vinson BA
    Nephrol Nurs J; 2021; 48(1):11-17. PubMed ID: 33683840
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Advanced practice nurses in ESRD: varied roles and a cost analysis.
    Holley JL; McGuirl K
    Nephrol News Issues; 2000 Feb; 14(3):18-20, 23, 27 passim. PubMed ID: 11933348
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Trends in patient characteristics and first-year medical costs of older incident hemodialysis patients, 1995-2005.
    Mau LW; Liu J; Qiu Y; Guo H; Ishani A; Arneson TJ; Gilbertson DT; Dunning SC; Collins AJ
    Am J Kidney Dis; 2010 Mar; 55(3):549-57. PubMed ID: 20116913
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Current advances in the therapy of chronic renal failure and end stage renal disease.
    Warady B; Watkins SL
    Semin Nephrol; 1998 May; 18(3):341-54. PubMed ID: 9613874
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Kidney Failure? Dialysis is the only medical service without automatic inflation updates from Medicare. Some people are trying to change that.
    Zigmond J
    Mod Healthc; 2006 Nov; 36(44):6-7, 14-6, 1. PubMed ID: 17128943
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Payment systems for dialysis and their effects: a scoping review.
    Emrani Z; Amiresmaili M; Daroudi R; Najafi MT; Akbari Sari A
    BMC Health Serv Res; 2023 Jan; 23(1):45. PubMed ID: 36650516
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ESRD Payment Reform: First Do No Harm.
    Shen JI; Norris KC
    J Am Soc Nephrol; 2016 Oct; 27(10):2924-2926. PubMed ID: 27026369
    [No Abstract]   [Full Text] [Related]  

  • 76. Lower Erythropoietin Doses and Medicare Payment Reform: Win-Wins for Patients With End-stage Renal Disease.
    Steinbrook R
    JAMA Intern Med; 2016 Dec; 176(12):1749-1751. PubMed ID: 27775766
    [No Abstract]   [Full Text] [Related]  

  • 77. Global Dialysis Perspective: United States.
    Han Y; Saran R
    Kidney360; 2020 Oct; 1(10):1137-1142. PubMed ID: 35368785
    [No Abstract]   [Full Text] [Related]  

  • 78. Variations in Payment for Dialysis-Implications for Policy and Practice.
    Hirth RA; Shahinian VB
    JAMA Netw Open; 2022 Oct; 5(10):e2239139. PubMed ID: 36306136
    [No Abstract]   [Full Text] [Related]  

  • 79. Correction to: Changes in hemodialysis catheter management after introduction of the end-stage renal disease prospective payment system.
    Roetker NS; Guo H; Decker-Palmer MR; Peng Y; Wetmore JB
    BMC Nephrol; 2021 Mar; 22(1):93. PubMed ID: 33722187
    [No Abstract]   [Full Text] [Related]  

  • 80. Impact of the Changes in the End Stage Renal Disease Composite Rate.
    Health Care Financ Rev; 1989; 11(1):145-146. PubMed ID: 25372598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.